Cargando…

Association of TNF-α and CCL5 with response to interferon-based therapy in patients with HCV 1 genotype

AIM OF THE STUDY: To evaluate the role of potential genetic predictors –308G/A TNF-α and –403G/A CCL5 in treatment for HCV 1 genotype. MATERIAL AND METHODS: Treatment results of 130 patients with chronic hepatitis C 1 genotype according to different genotypes of IL28B, CCL5, and TNF-α were analysed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danilau, Dzmitry, Litvinchuk, Dzmitry, Solovey, Nikita, Krasko, Olga, Karpov, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497450/ https://www.ncbi.nlm.nih.gov/pubmed/28856285 http://dx.doi.org/10.5114/ceh.2017.65279

Ejemplares similares

Ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin for treatment of chronic hepatitis C 1 genotype in the Republic of Belarus
por: Danilau, Dzmitry, et al.
Publicado: (2017)

Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV
por: Wang, Wenshi, et al.
Publicado: (2016)

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
por: Kozielewicz, Dorota, et al.
Publicado: (2018)

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
por: Muazzam, Ambreen G, et al.
Publicado: (2011)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Kinetic response of wild and mutant core codon 70 strains of HCV genotype 1b to pegylated interferon-α and ribavirin therapy
por: Hu, Zhongjie, et al.
Publicado: (2015)

Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis
por: Badra, Gamal, et al.
Publicado: (2006)

Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition
por: Soria, Gali, et al.
Publicado: (2011)

Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population
por: Mansoor, Atika, et al.
Publicado: (2013)

Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells
por: Grunz-Borgmann, Elizabeth, et al.
Publicado: (2015)

Human Neutrophils Produce CCL23 in Response to Various TLR-Agonists and TNFα
por: Arruda-Silva, Fabio, et al.
Publicado: (2017)

A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection
por: Kishida, Yutaka, et al.
Publicado: (2016)

IL-10 and TNFα Genotypes in SLE
por: López, Patricia, et al.
Publicado: (2010)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Clearance of HCV by Combination Therapy of Pegylated Interferon α-2a and Ribavirin Improves Insulin Resistance
por: Kim, Hong Joo, et al.
Publicado: (2009)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study
por: Kleefeld, Felix, et al.
Publicado: (2017)

Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson’s Disease Severity
por: Xiromerisiou, Georgia, et al.
Publicado: (2022)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
por: Tronina, Olga, et al.
Publicado: (2023)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Effect of Essential Oils on the Release of TNF-α and CCL2 by LPS-Stimulated THP‑1 Cells
por: Miguel, Maria Graça, et al.
Publicado: (2020)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
por: Niederau, Claus, et al.
Publicado: (2014)

Altered Thymic Function during Interferon Therapy in HCV-Infected Patients
por: Beq, Stephanie, et al.
Publicado: (2012)

Dental problems delaying the initiation of interferon therapy for HCV-infected patients
por: Nagao, Yumiko, et al.
Publicado: (2010)

Analysis of the factors motivating HCV-infected patients to accept interferon therapy
por: Nagao, Yumiko, et al.
Publicado: (2012)

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
por: Warkad, Shrikant Dasharath, et al.
Publicado: (2018)

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4
por: Shaker, Olfat, et al.
Publicado: (2013)

Serum Lipoprotein Profiles and Response to Pegylated Interferon Plus Ribavirin Combination Therapy in Patients With Chronic HCV Genotype 1b Infection
por: Aizawa, Yoshio, et al.
Publicado: (2013)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

CCL2 has similar excitatory effects to TNF-α in a subgroup of inflamed C-fiber axons
por: Richards, Natalie, et al.
Publicado: (2011)

Evaluation of the Effects of Some Brazilian Medicinal Plants on the Production of TNF-α and CCL2 by THP-1 Cells
por: Gusman, Grasielle S., et al.
Publicado: (2015)

Diverse expression of TNF-α and CCL27 in serum and blister of Stevens–Johnson syndrome/toxic epidermal necrolysis
por: Wang, Fang, et al.
Publicado: (2018)

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs
por: Huik, Kristi, et al.
Publicado: (2016)

Interferon Alpha Therapy in Patients with Chronic Type C Hepatitis: Changes of Serum ALT, Anti-HCV & HCV-RNA
por: Cho, Ho Jun, et al.
Publicado: (1992)

Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran
por: Hesamizadeh, Khashayar, et al.
Publicado: (2019)

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
por: Malaguarnera, Giulia, et al.
Publicado: (2016)

Recent advances in the anti-HCV mechanisms of interferon
por: Huang, Menghao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g0lrt3oudqts8vt4rr67rev7sp